Blood‐brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors

To investigate the blood‐brain barrier (BBB function), serum and cerebro‐spinal fluid (CSF) from 118 patients with Alzheimer's disease (AD) and 50 healthy controls was analyzed with regard to albumin concentrations. For the AD group, clinical vascular factors were also recorded. The CSF/serum albumin ratio was used as a measure of BBB function. When compared with controls, the AD group showed a higher mean albumin ratio, indicating a decline in BBB function. However, no significant reduction in BBB function was found in AD patients without vascular factors. These findings support the hypothesis that BBB disturbance is related to vascular factors, coexisting with AD. In the control group, no significant correlation between age and albumin ratio was found, which suggests that aging per se is not primarily associated with a decline in BBB function. The present study provides evidence in favour of the conclusion that a reduced BBB function is related neither to AD nor to aging, but to clinical vascular factors.

[1]  B. Tavolato,et al.  Alzheimer's disease and senile brains: an immunofluorescence study. , 1983, Rivista di patologia nervosa e mentale.

[2]  H. Tanabe,et al.  Conduction aphasia and arcuate fasciculus , 1987, Acta neurologica Scandinavica.

[3]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[4]  C. Masters,et al.  The blood-brain barrier in Alzheimer's disease and normal aging , 1988, Neurobiology of Aging.

[5]  H. Wiśniewski,et al.  Evidence for Blood‐Brain Barrier Changes in Senile Dementia of the Alzheimer Type (SDAT) , 1982, Annals of the New York Academy of Sciences.

[6]  T. Sjogren,et al.  Morbus Alzheimer and morbus Pick; a genetic, clinical and patho-anatomical study. , 1952, Acta psychiatrica et neurologica Scandinavica. Supplementum.

[7]  G. Glenner.  Congophilic microangiopathy in the pathogenesis of Alzheimer's syndrome (presenile dementia). , 1979, Medical hypotheses.

[8]  T. Milhorat,et al.  Cerebrospinal Fluid as Reflection of Internal Milieu of Brain , 1983 .

[9]  S. Rapoport,et al.  CSF and serum concentrations of albumin and IgG in Alzheimer's disease , 1987, Neurobiology of Aging.

[10]  Stanley I. Rapoport,et al.  Blood-Brain Barrier in Physiology and Medicine , 1976 .

[11]  T. Erkinjuntti.  Differential diagnosis between Alzheimer's disease and vascular dementia: evaluation of common clinical methods , 1987, Acta neurologica Scandinavica.

[12]  K. Blennow,et al.  Presence of parieto‐temporal symptomatology distinguishes early and late onset Alzheimer's disease , 1991 .

[13]  T. Erkinjuntti,et al.  Oligoclonal immunoglobulin bands in cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia , 1988, Acta neurologica Scandinavica.

[14]  C. Loeb,et al.  Diagnostic evaluation of degenerative and vascular dementia. , 1983, Stroke.

[15]  J. Hardy,et al.  An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease , 1986, Neurobiology of Aging.

[16]  K. Blennow,et al.  Blood brain barrier function in vascular dementia , 1990, Acta neurologica Scandinavica.

[17]  K. Breebaart,et al.  Investigation of Reference Values of Components of Cerebrospinal Fluid , 1978, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[18]  T. Erkinjuntti,et al.  CSF in Alzheimer's disease: Studies on blood-brain barrier function and intrathecal protein synthesis , 1985, Journal of the Neurological Sciences.

[19]  A. Mooradian.  Effect of aging on the blood-brain barrier , 1988, Neurobiology of Aging.

[20]  P. Yates,et al.  IMMUNOHISTOCHEMICAL STAINING OF SENILE PLAQUES , 1982, Neuropathology and applied neurobiology.

[21]  G. Tibbling,et al.  Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid. , 1977, Scandinavian journal of clinical and laboratory investigation.

[22]  K. Felgenhauer,et al.  Evaluation of the blood-CSF barrier by protein gradients and the humoral immune response within the central nervous system , 1976, Journal of the Neurological Sciences.

[23]  C. Gandolfo,et al.  The integrity of the blood—Brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid , 1985, Journal of the Neurological Sciences.